This resource was created by SMI Adviser content partners and approved by the SMI Adviser clinical expert team for inclusion in the knowledge base.
Long-acting injectable antipsychotics (LAIs) are a pharmacologic strategy for treating individuals who have schizophrenia. Rather than the daily pill-taking required with oral antipsychotics, LAIs are administered by injection at two- to four-week intervals.
This fact sheet provides an overview of potential barriers to using LAIs, possible outcomes and side effects, and how to discuss LAIs with individuals and families.